Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Share Price Hits New 52-Week High
- July 30, 2026
- Posted by: Harsh Piplani
- Category: News
Sun Pharmaceutical Industries Ltd. Share Price hits a new 52-week high at Rs 2,009.85, gaining 0.89% today. Market cap stands at Rs 4,74,396.51 crore.
Sun Pharmaceutical Industries Ltd. Share Price reached a new 52-week high today, closing at Rs 2,009.85. The stock opened at Rs 1,999.45 and experienced a day change of 0.89%, with a closing price of Rs 2,007.45. The market capitalisation of Sun Pharmaceutical Industries Ltd. is Rs 4,74,396.51 crore, reflecting its significant presence in the healthcare sector. This fresh 52-week high highlights the stock’s recent momentum, drawing investor attention to its performance and market position.
Sun Pharmaceutical Industries Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,007.45 |
| Previous Close | Rs 1,989.75 |
| Today's Change | +Rs 17.7 (+0.89%) |
| Day Open | Rs 1,999.45 |
| Fresh 52-Week High | Rs 2,009.85 |
| Day Low | Rs 1,989.75 |
| Current Volume | 10,434 |
| Turnover | Rs 2.09 crore |
| Market Capitalisation | Rs 4,74,396.51 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) traded at Rs 2,007.45. versus the previous close of Rs 1,989.75, a rise of 0.89%. The stock opened at Rs 1,999.45, reached Rs 2,009.85, touched Rs 1,989.75. Reported volume was 10,434.
Today, Sun Pharmaceutical Industries Ltd. Share Price opened at Rs 1,999.45 and reached a high of Rs 2,009.85, marking a fresh 52-week peak. The stock closed at Rs 2,007.45, up by 0.89% from the previous close of Rs 1,989.75. The day’s low was Rs 1,989.75, and the turnover was Rs 2.09 crore with a volume of 10,434 shares. This price action indicates a positive trend, with the stock breaking its previous yearly high, suggesting increased investor interest.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,74,396.51 crore |
| P/E Ratio | 30.28x |
| P/B Ratio | 0.44x |
| ROE | -2.89% |
| ROCE | -0.26% |
Sun Pharmaceutical Industries Ltd. was valued at a P/E ratio of 30.28x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 30.28x |
| Benchmark Median P/E | 21.7x |
| Benchmark Average P/E | 68.16x |
| Benchmark P/E Range | 0x to 3,385.56x |
| Company P/B Ratio | 0.44x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.73% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 4,74,396.51 crore |
| Benchmark Median Market Cap | Rs 138.42 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) is classified under sector: Healthcare.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 30.28x, which is above the benchmark median of 21.7x, a difference of +39.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROE of -2.89%, which is below the benchmark median of 10.73%, a difference of -126.93%. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,856.59 | 30.28 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,686.76 | 40.11 | 8.17 | 28.21 | 26.35 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,432.22 | 34.7 | 7.02 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,415.06 | 171.06 | 3.16 | 13.9 | 12.97 |
| Beta Drugs Ltd. | BETA | 2,338.9 | 59.68 | 9.44 | 18.65 | 22.17 |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 30.28x compared with the displayed peer median of 40.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a market capitalisation of Rs 4,74,396.51 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. Share Price hits a new 52-week high at Rs 2,009.85.
- Positive price action with a 0.89% increase today.
- High market capitalisation of Rs 4,74,396.51 crore.
- Sector P/E and P/B comparisons highlight valuation context.
- Peer analysis shows areas for profitability improvement.
About Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is a leading player in the healthcare sector, known for its extensive range of pharmaceutical products. The company operates across various segments, providing innovative solutions in the field of pharmaceuticals and healthcare. With a strong market presence, Sun Pharma continues to focus on research and development to enhance its product offerings and maintain its competitive edge in the industry.
Track Sun Pharmaceutical Industries Ltd. Share Price on Univest
Use Sun Pharmaceutical Industries Ltd. (SUNPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Sun Pharmaceutical Industries Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest for comprehensive analysis and informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Sun Pharmaceutical Industries Ltd.?
Ans. The current share price of Sun Pharmaceutical Industries Ltd. is Rs 2,007.45, marking a 0.89% increase from the previous close. The stock moved 0.89% during the session. The intraday range extended from Rs 1,989.75 to Rs 2,009.85.
What is the market capitalisation of Sun Pharmaceutical Industries Ltd.?
Ans. The market capitalisation of Sun Pharmaceutical Industries Ltd. is Rs 4,74,396.51 crore, reflecting its significant size in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.28x.
How does Sun Pharma's P/E ratio compare to the sector?
Ans. Sun Pharma's P/E ratio of 30.28 is above the sector median of 21.7 but below the average of 68.16, indicating a moderate valuation. The company trades at a P/E ratio of 30.28x.
What are the ROE and ROCE of Sun Pharmaceutical Industries Ltd.?
Ans. Sun Pharmaceutical Industries Ltd. has an ROE of -2.89% and a ROCE of -0.26%, both below sector averages, indicating areas for improvement. ROE stands at -2.89%. ROCE stands at -0.26%.
Which peers are compared with Sun Pharmaceutical Industries Ltd.?
Ans. Peers compared include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Dr Agarwals Eye Hospital Ltd., Sai Parenteral's Ltd., and Beta Drugs Ltd. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Dr Agarwals Eye Hospital Ltd.
What is the significance of the 52-week high for Sun Pharma?
Ans. The 52-week high of Rs 2,009.85 signifies strong market momentum and increased investor interest in Sun Pharmaceutical Industries Ltd. The stock moved 0.89% during the session. The intraday range extended from Rs 1,989.75 to Rs 2,009.85.
How does Sun Pharma's P/B ratio compare to the sector?
Ans. Sun Pharma's P/B ratio of 0.44 is significantly lower than the sector median of 1.9, suggesting a lower valuation on a book value basis. The company trades at a P/E ratio of 30.28x.
Where can I track Sun Pharmaceutical Industries Ltd. Share Price?
Ans. You can track Sun Pharmaceutical Industries Ltd. Share Price and other market insights on Univest for comprehensive analysis. The stock moved 0.89% during the session. The intraday range extended from Rs 1,989.75 to Rs 2,009.85.
